Elliott S - Search Results

1

Andrews DA, Boren BM, Turk JR, Boyce RW, He YD, Hamadeh HK, Mytych DT, Barger TE, Salimi-Moosavi H, Sloey B, Elliott S, McElroy P, Sinclair AM, Shimamoto G, Pyrah IT, Lightfoot-Dunn RM. Andrews DA, et al. Among authors: elliott s. Toxicol Pathol. 2014;42(3):524-39. doi: 10.1177/0192623313486319. Epub 2013 May 14. Toxicol Pathol. 2014. PMID: 23674391

2

Kinetics of haematopoietic recovery after dose-intensive chemo/radiotherapy in mice: optimized erythroid support with darbepoetin alpha.

Hartley C, Elliott S, Begley CG, McElroy P, Sutherland W, Khaja R, Heatherington AC, Graves T, Schultz H, Del Castillo J, Molineux G. Hartley C, et al. Among authors: elliott s. Br J Haematol. 2003 Aug;122(4):623-36. doi: 10.1046/j.1365-2141.2003.04467.x. Br J Haematol. 2003. PMID: 12899718 Free article.

3

Structural requirements for additional N-linked carbohydrate on recombinant human erythropoietin.

Elliott S, Chang D, Delorme E, Eris T, Lorenzini T. Elliott S, et al. J Biol Chem. 2004 Apr 16;279(16):16854-62. doi: 10.1074/jbc.M311095200. Epub 2004 Feb 2. J Biol Chem. 2004. PMID: 14757769 Free article.

4

Comparison of epoetin alfa and darbepoetin alfa biological activity under different administration schedules in normal mice.

Sasu BJ, Hartley C, Schultz H, McElroy P, Khaja R, Elliott S, Egrie JC, Browne JK, Begley CG, Molineux G. Sasu BJ, et al. Among authors: elliott s. Acta Haematol. 2005;113(3):163-74. doi: 10.1159/000084446. Acta Haematol. 2005. PMID: 15870486

5

Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins.

Sinclair AM, Elliott S. Sinclair AM, et al. Among authors: elliott s. J Pharm Sci. 2005 Aug;94(8):1626-35. doi: 10.1002/jps.20319. J Pharm Sci. 2005. PMID: 15959882 Review.

6

Anti-Epo receptor antibodies do not predict Epo receptor expression.

Elliott S, Busse L, Bass MB, Lu H, Sarosi I, Sinclair AM, Spahr C, Um M, Van G, Begley CG. Elliott S, et al. Blood. 2006 Mar 1;107(5):1892-5. doi: 10.1182/blood-2005-10-4066. Epub 2005 Oct 25. Blood. 2006. PMID: 16249375 Free article.

7

Expression and function of erythropoietin receptors in tumors: implications for the use of erythropoiesis-stimulating agents in cancer patients.

Sinclair AM, Todd MD, Forsythe K, Knox SJ, Elliott S, Begley CG. Sinclair AM, et al. Among authors: elliott s. Cancer. 2007 Aug 1;110(3):477-88. doi: 10.1002/cncr.22832. Cancer. 2007. PMID: 17582631 Free article. Review.

8

Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells.

Sinclair AM, Rogers N, Busse L, Archibeque I, Brown W, Kassner PD, Watson JE, Arnold GE, Nguyen KC, Powers S, Elliott S. Sinclair AM, et al. Among authors: elliott s. Br J Cancer. 2008 Mar 25;98(6):1059-67. doi: 10.1038/sj.bjc.6604220. Epub 2008 Mar 18. Br J Cancer. 2008. PMID: 18349818 Free PMC article.

9

Identification of a sensitive anti-erythropoietin receptor monoclonal antibody allows detection of low levels of EpoR in cells.

Elliott S, Busse L, McCaffery I, Rossi J, Sinclair A, Spahr C, Swift S, Begley CG. Elliott S, et al. J Immunol Methods. 2010 Jan 31;352(1-2):126-39. doi: 10.1016/j.jim.2009.10.006. Epub 2009 Nov 1. J Immunol Methods. 2010. PMID: 19887071

10

Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells.

Sinclair AM, Coxon A, McCaffery I, Kaufman S, Paweletz K, Liu L, Busse L, Swift S, Elliott S, Begley CG. Sinclair AM, et al. Among authors: elliott s. Blood. 2010 May 27;115(21):4264-72. doi: 10.1182/blood-2009-10-248666. Epub 2010 Feb 2. Blood. 2010. PMID: 20124513 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,125 results

Search Page

Filters